R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.

Journal: Journal of comparative effectiveness research
PMID: 39601215

Abstract

In this update, we discuss a position statement from the National Institute of Health and Care Excellence (NICE) on the use of artificial intelligence for evidence generation and publications reviewing the use of real-world data as external control arms. Finally, we discuss a number of recent studies investigating the real-world effectiveness of glucagon-like peptide-1 receptor agonists and whether these studies are informative for reimbursement decision making.

Authors

  • Paul Arora
    Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Lighthouse Outcomes, Toronto, ON, Canada. Electronic address: paul.arora@utoronto.ca.
  • Sreeram V Ramagopalan
    Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK.

Keywords

External Resources

Popular Topics
Recent Journals